Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.
Marco RusnatiAntonella BugattiStefania MitolaDaria LealiPaolo BergeseLaura E. DeperoMarco PrestaPublished in: Sensors (2009)